From Haze to Skunk, OG to Cookies, the cannabis market has been shaped by remarkable strains that encapsulate their respective eras. Among them, Blue Dream emerged as a defining cultivar around 2003, reigning until approximately 2011 when shifting market preferences opened the door for a new strain to take the spotlight. As we commemorate two decades of Blue Dream’s legacy, it’s intriguing to note that despite its celebrated status as the “most popular strain on the planet” at one point, there remains a surprising shroud of uncertainty surrounding its true origins and characteristics.

Unveiling Blue Dream’s Genetic Ancestry

The enigmatic origins of Blue Dream continue to mystify experts and enthusiasts alike. While the identity of its original breeder remains a mystery, a prevailing consensus exists about its genetic lineage. Renowned cannabis breeder Ed Rosenthal, as reported by Ellen Holland in her seminal piece on Blue Dream’s history for High Times, revealed that this strain is a hybrid of “Haze and DJ Short’s Blueberry.” This assertion is corroborated by various online sources. Yet, a mild debate persists regarding the specific Blueberry cultivar and the type of Haze involved. Jason Matthys, founder of Equilibrium Genetics, has disclosed that the Haze used might have been from Corralitos, hinting at the Santa Cruz Haze rather than Super Silver Haze. The subtle distinctions in these genetics cast intriguing shadows on Blue Dream’s true lineage.

Unraveling the Mystery of a “Second” Blue Dream

Whispers of not one, but two variants of Blue Dream have circulated within cannabis circles. While some argue that one version leans more toward sativa while the other veers indica, clarity eludes this speculation. Eva Erikson of Haze Valley Nursery shared insights into the rumor, suggesting that the “imposter Blue Dream” could be an offshoot bred from the original. This discrepancy might arise from the choice between DJ Short’s Blueberry and Super Silver Haze in the breeding process, or it could even reflect variations influenced by environmental factors rather than genetic differences.

Architects of Blue Dream’s Success

Unveiling the mastermind behind Blue Dream’s meteoric rise proves equally elusive. Various leads have been pursued, yet the original breeder remains concealed. Speculations abound, with some tracing its lineage to the patient group WAMM, while others highlight the hills above Bonny Doon as a probable birthplace. The cannabis community’s efforts to pinpoint the true creator have been met with intriguing dead-ends, leaving a sense of enduring mystery.

A Symphony of Flavors and Terpenes

Blue Dream’s flavor profile is a harmonious blend of its parent strains, with the Blueberry influence taking precedence over Haze. Descriptions range from simple blueberry notes to intricate comparisons with blueberry muffins, occasionally punctuated by hints of sandalwood or musk from the Haze side. Terpene analyses often reveal dominant compounds like beta myrcene, alpha pinene, and beta caryophyllene, imparting sweet, spicy, and woody aromas. Interestingly, blueberries themselves contain cineole and linalool, shedding light on the diverse bouquet within Blue Dream’s fragrance.

The Rise, Fall, and Resurgence

Blue Dream’s narrative reflects the tumultuous Green Rush era, where its popularity skyrocketed due to its ease of cultivation, high THC content, and enticing aroma. However, overproduction during this phase led to diluted quality as novice cultivators rushed the growing process. Despite encountering a decline due to this influx of subpar offerings, Blue Dream is experiencing a revival. Craig and Melanie Johnson, growers at Alpenglow Farms, concur that quality suffered due to rapid harvesting, preventing the strain from reaching its full potential. The market’s evolution since the Green Rush is breathing new life into Blue Dream, as enthusiasts seek the authentic experience of this classic cultivar.

Blue Dream’s Legacy

The story of Blue Dream, spanning two decades, is one of enduring allure and transformation. While questions linger about its genetic lineage and originator, this strain’s impact on the cannabis landscape remains undeniable. A harmonious fusion of flavors, terpenes, and effects contributed to its initial success, only to be challenged by quality concerns during the Green Rush. Now, as the cannabis industry matures, Blue Dream is poised for a triumphant resurgence, a reminder of its enduring legacy amid an ever-evolving market.

Source: High Times

EXPLORE MORE NEWS

The Missouri Division of Cannabis Regulation (DCR) has recently taken a significant step in the cannabis industry by issuing a recall of more than 62,000 cannabis products manufactured by Delta Extraction, LLC. The reason behind this recall lies in the fact that these products were not being compliantly tracked in the statewide track and trace system known as METRC. This failure to adhere to tracking protocols created a situation where the DCR could not verify the origins of these products – whether they were sourced from marijuana cultivated within Missouri and had undergone the necessary testing procedures.

The scope of this recall encompasses a wide range of cannabis-infused products, including tinctures, vape cartridges, gel capsules, tablets, and other similar items. To ensure public safety, the DCR has strongly recommended that consumers who have purchased any of these affected products take appropriate action. They can either discard these items or return them to the dispensary where they were originally purchased. Importantly, the DCR has reassured consumers that these returns will not impact their established monthly purchase limits, providing a degree of comfort to those affected.

The DCR has been proactive in promoting awareness among consumers regarding the risks associated with marijuana products that have not been appropriately tracked in the METRC system. By urging consumers to follow the prescribed disposal or return procedures, the DCR is attempting to safeguard the well-being of the public.

Additionally, the DCR has emphasized the significance of reporting any adverse reactions related to the use of these products. They have provided channels for reporting such reactions, including email and an online complaint form, underlining their commitment to ensuring consumer safety.

The context leading up to this recall involves a lengthy hearing at the Administrative Hearing Commission. During this hearing, Delta Extraction challenged the immediate suspension of its license by the Missouri Department of Health and Senior Services (DHSS). The suspension followed the discovery that Delta Extraction had incorporated out-of-state hemp-derived THCa into its marijuana products. THCa is the non-psychoactive compound in marijuana that converts into THC when heated, producing the characteristic “high.”

Delta Extraction’s representative, Jack Maritz, asserted that the distillation process allowed for the utilization of out-of-state hemp-derived THCa. The company’s position was based on previous state regulations that seemed to permit this practice. However, the state counterargued that recent regulations had clarified the prohibition of such practices. The outcome of the hearing remains pending, as the Administrative Hearing Commission has yet to decide on the reinstatement of Delta Extraction’s license.

Rachael Herndon, Delta’s chief operational officer, highlighted the adverse effects of the license suspension on the company’s reputation and financial standing. She stated, “Our reputation was damaged, and we had over $10 million in product on our site immediately locked up.”

This recall serves as a poignant reminder to both cannabis producers and consumers about the ever-evolving landscape of rules and regulations in the cannabis industry. The rapid shifts in policies underline the necessity for all stakeholders – including manufacturers, dispensaries, patients, and consumers – to remain diligently informed about the most current guidelines and procedures. By staying up-to-date, the industry can collectively work towards maintaining high standards of safety and compliance.

Source: Beardbrospharms

EXPLORE MORE NEWS

Can it find acceptance in Peoria? This quintessential American question examines the likelihood of a new trend, behavior, or occurrence gaining widespread approval. The term “Peoria” refers to the city in Illinois and embodies the notion that if a concept gains traction in the Midwest, it attains a mainstream status. When the wave of cannabis legalization emerged in 2012, it primarily took root in predictable locales – the coasts. Early victories for legalization in states like Colorado, Oregon, Washington, and Maine were not unexpected, given their reputation for a blend of progressive and Libertarian-leaning politics. However, the real question lingered: When would this movement extend to the Heartland? The answer arrived in 2018, when Michigan became the first Midwestern state to endorse adult-use legalization. With progressive pockets such as Ann Arbor and the presence of an urban hub like Detroit, Michigan might have been perceived as an outlier. Subsequently, Illinois followed suit in 2020, and to the astonishment of many, Missouri in 2022. The latest addition to this Midwestern lineup is Minnesota, with its recent introduction of an adult-use cannabis initiative. Ohio aims to place a similar measure on the ballot in 2024. As for Iowa, Indiana, and Wisconsin? The prospect appears remote.

This raises an intriguing query: Does the consumption behavior of Midwestern cannabis users diverge from that of the broader adult-use population? If so, might these distinctions be tied to the lingering stigma in these states? In commemoration of Minnesota’s program launch, we delved into usage frequency and favored ingestion methods of Midwestern consumers in adult-use states (MI, IL, and MO) versus the general U.S. adult-use consumer populace.

In comparison to their counterparts across all adult-use markets in the U.S., Midwestern consumers exhibit a slightly higher likelihood of reporting multiple daily cannabis usage instances (34% vs. 31%). Conversely, they are somewhat less inclined to report consuming cannabis once every day or every other day (28% vs. 32%). The extended history of cannabis prohibition and the persisting stigma in this region (excluding Ann Arbor, MI, which decriminalized cannabis possession in 1974, not without contention) could signify that legalization has unlocked opportunities that citizens are eagerly seizing.

Midwest Product Preferences

Midwestern consumers express a marginal inclination towards favoring edibles when contrasted with the general adult-use consumer populace (26% vs. 22%). This variance might arise from the lingering societal apprehension towards cannabis, motivating discreet consumption. Alternatively, given that states like California and New York boasted thriving unregulated markets before legalization, the accessibility of edibles might have been more limited in Midwestern markets, rendering them an appealing novelty for many consumers.

So, can it indeed find approval in Peoria? It is conceivable, albeit with caveats. The clutches of prohibition and the persistent misconceptions surrounding cannabis consumption continue to hold sway in various states across the U.S. The legalization of cannabis in these regions could be attributed to the revenue drain experienced as residents travel to neighboring legal states. Witnessing cannabis legalization in the Wholesome Heartland, however, signifies a paradigm shift, marking a society that has transcended viewing cannabis as the “devil’s lettuce” and is ready to advance beyond the “Just Say No” era.

Source: Newfrontierdata

EXPLORE MORE NEWS

Setting the stage, it’s important to note that 24 U.S. states have legalized both Adult-Use and Medical-Use cannabis, 16 states have sanctioned Medical-Use exclusively, and 11 states maintain no legal cannabis market whatsoever. This translates to nearly 75% of Americans, roughly 250 million individuals, residing in states with varying degrees of access to high-THC legal cannabis. According to New Frontier Data’s analysis, the U.S. cannabis market’s legal sales were estimated at approximately $30 billion in 2022, and projections indicate they are poised to surpass $35 billion in 2023.

Despite the industry’s ongoing journey toward mainstream acceptance, it grapples with multifaceted challenges including federal policy inaction, downward price pressures, and limited access to capital. However, a particularly significant thorn in the industry’s side is the persistent dominance of the illicit market.

Illicit cannabis sales skyrocketed to $77 billion in 2022, more than double the total legal sales during the same period. Even within existing legal markets, New Frontier Data’s forecasts indicate that the illicit market will maintain its stronghold over legal sales until 2030.

Notably, an increasing number of consumers are opting to purchase their cannabis from brick-and-mortar dispensaries. A substantial 43% of current consumers revealed that their primary cannabis source is a physical dispensary—an impressive upswing from the previous year’s 34%. It’s evident that local market dynamics play a pivotal role in determining where consumers choose to procure their cannabis products.

Anticipating future developments, it’s anticipated that new markets will emerge in the coming years. To explore a comprehensive list of markets tracked by New Frontier Data and their anticipated timelines for legalization, one can refer to the 2023 U.S. Cannabis Report. The advent of these markets would likely propel annual legal market sales forward, potentially enabling legal sales to surpass illicit sales by 2028. By 2030, it’s projected that the legal market could account for 58% of all cannabis sales in the United States.

When comparing the current landscape of legal states to this potential model, a remarkable $13 billion (equivalent to a 22% growth) in annual sales could materialize by 2030. Furthermore, if these states proceed to expand legal access within the next few years, only three states would remain devoid of a legal cannabis market. This scenario would signify that an impressive 94% of Americans would reside in states where some form of high-THC legal cannabis is accessible.

For those seeking deeper insights into the cannabis industry’s most pressing challenges and promising opportunities, as well as an exploration of shifting consumer preferences since the previous year, a valuable resource is Equio—an essential reference point for staying informed.

Source: NewFrontierData

EXPLORE MORE NEWS